We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

JUN 26 2018

Pricing Drugs, Selling Hype and How We Got Here in the First Place

FierceBiotech chats with William Garvin, Shareholder in the firm's FDA & Biotechnology practice, about how drug pricing is unique in the U.S. and how the biopharma environment lends itself to selling hype and securities fraud.